Conte P - Search Results

1

Overall Survival with Ribociclib plus Letrozole in Advanced Breast Cancer.

Hortobagyi GN, Stemmer SM, Burris HA, Yap YS, Sonke GS, Hart L, Campone M, Petrakova K, Winer EP, Janni W, Conte P, Cameron DA, André F, Arteaga CL, Zarate JP, Chakravartty A, Taran T, Le Gac F, Serra P, O'Shaughnessy J. Hortobagyi GN, et al. Among authors: conte p. N Engl J Med. 2022 Mar 10;386(10):942-950. doi: 10.1056/NEJMoa2114663. N Engl J Med. 2022. PMID: 35263519 Clinical Trial.

2

Cisplatin and 5-fluorouracil in advanced and recurrent cervical cancer.

Chiara S, Consoli R, Falcone A, Bruzzone M, Foglia G, Ragni N, Conte PF. Chiara S, et al. Among authors: conte pf. Tumori. 1988 Aug 31;74(4):471-4. doi: 10.1177/030089168807400415. Tumori. 1988. PMID: 3188245

3

A phase II study with danazol in metastatic breast cancer.

Pronzato P, Amoroso D, Ardizzoni A, Bertelli G, Conte PF, Michelotti A, Rosso R. Pronzato P, et al. Among authors: conte pf. Am J Clin Oncol. 1987 Oct;10(5):407-9. doi: 10.1097/00000421-198710000-00008. Am J Clin Oncol. 1987. PMID: 3661491

4

Long-term prognosis following macroscopic complete response at second-look laparotomy in advanced ovarian cancer patients treated with platinum-based chemotherapy. The Gruppo Oncologico Nord Ovest.

Chiara S, Lionetto R, Campora E, Oliva C, Merlini L, Bruzzi P, Rosso R, Conte PF. Chiara S, et al. Among authors: conte pf. Eur J Cancer. 1995;31A(3):296-301. doi: 10.1016/0959-8049(94)00487-p. Eur J Cancer. 1995. PMID: 7786592 Clinical Trial.

5

Tumour kinetics, response to chemotherapy and survival in primary ovarian cancer.

Alama A, Chiara S, Merlo F, Ragni N, Conte PF, Meazza R, Reggiardo G, Ferrari I, Rosso R. Alama A, et al. Among authors: conte pf. Eur J Cancer. 1994;30A(4):449-52. doi: 10.1016/0959-8049(94)90416-2. Eur J Cancer. 1994. PMID: 8018401 Clinical Trial.

6

Analysis of time to response to chemotherapy in 316 metastatic breast cancer patients.

Pronzato P, Bertelli G, Gardin G, Rubagotti A, Conte PF, Rosso R. Pronzato P, et al. Among authors: conte pf. Oncology. 1993 Nov-Dec;50(6):460-5. doi: 10.1159/000227230. Oncology. 1993. PMID: 8233288 Clinical Trial.

7

Advanced ovarian cancer. Carboplatin versus cisplatin.

Vermorken JB, ten Bokkel Huinink WW, Eisenhauer EA, Favalli G, Belpomme D, Conte PF, Kaye SB. Vermorken JB, et al. Among authors: conte pf. Ann Oncol. 1993;4 Suppl 4:41-8. Ann Oncol. 1993. PMID: 8312200 Review.

8

The impact of received dose intensity on the outcome of advanced ovarian cancer.

Repetto L, Pace M, Mammoliti S, Bruzzone M, Chiara S, Oliva C, Guido T, Conte PF, Campora E, Rubagotti A, et al. Repetto L, et al. Among authors: conte pf. Eur J Cancer. 1993;29A(2):181-4. doi: 10.1016/0959-8049(93)90169-g. Eur J Cancer. 1993. PMID: 8422279 Clinical Trial.

9

Activity and safety of epirubicin plus paclitaxel in advanced breast cancer.

Conte PF, Michelotti A, Baldini E, Tibaldi C, DaPrato M, Salvadori B, Giannessi PG, Gentile A, Biadi O, Mariani M. Conte PF, et al. Semin Oncol. 1996 Feb;23(1 Suppl 1):28-32. Semin Oncol. 1996. PMID: 8629033

10

Paclitaxel in combination with vinorelbine in pretreated advanced breast cancer patients.

Michelotti A, Gennari A, Salvadori B, Giannessi PG, Baldini E, Tibaldi C, Da Prato M, Conte PF. Michelotti A, et al. Among authors: conte pf. Semin Oncol. 1996 Oct;23(5 Suppl 11):38-40. Semin Oncol. 1996. PMID: 8893898 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

770 results

Search Page